New data suggests that, after several volatile years, the behavioral health sector is regaining favor among strategic and financial buyers.
In the first quarter, 47 transactions were reported, including 34 mergers and acquisitions. That’s the highest M&A volume since the fourth quarter of 2022, according to investment banker Kevin Taggart.
In a blog post published this week, Taggart explained that renewed interest in the intellectual and developmental disabilities (I/DD) and autism segments was a key driver of the momentum. The firm tallied 12 transactions in Q1, the highest level since 2021.
Applied behavior analysis (ABA) therapy providers, in particular, are back in high demand.
"The dust has seemed to settle" following the pandemic-era wage inflation and a wave of bankruptcies among large ABA providers, Taggart, a managing partner at Mertz Taggart, wrote. That shift has led to heightened buyer interest, especially in the wake of major exits.
The mental health subsector continues to show strong and steady deal flow, too. Twenty-nine transactions (19 M&A and 10 growth investments) were announced in Q1, roughly matching the 30 deals reported in Q4 2024.
Demand for psychiatric hospitals is particularly robust, though limited supply constrains deal volume. "We've had more groups ask us for psych hospitals since Q1 this year than probably any quarter in the last three or four years," Taggart said. "But there are fewer smaller operators out there."
Taggart also pointed to an ongoing trend: sustained investor appetite for high-valuation growth deals. "Money has continued to pour into these growth deals, which surprised us a bit," he said, signaling continued bullish sentiment across behavioral health verticals.
For last week’s edition of the Deal Dispatch, click here.
Read Next:
Image created using a photo from Shutterstock